Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases

被引：22

作者：

Bradley, Mark ^{[1
]}

Taylor, Rachel ^{[2
]}

Jacobson, Julie ^{[3
]}

Guex, Morgane ^{[4
]}

Hopkins, Adrian ^{[5
]}

Jensen, Julie ^{[6
]}

Leonard, Lynn ^{[7
]}

Waltz, Johannes ^{[8
]}

Kuykens, Luc ^{[9
]}

Sow, Papa Salif ^{[10
]}

Madeja, Ulrich-Dietmar ^{[11
]}

Hida, Takayuki ^{[12
]}

Ole-Moiyoi, Kileken ^{[13
]}

King, Jonathan ^{[14
]}

Argaw, Daniel ^{[14
]}

Mohamed, Jamsheed ^{[15
]}

Polo, Maria Rebollo ^{[16
]}

Yajima, Aya ^{[17
]}

Ottesen, Eric ^{[18
]}

机构：

[1] GSK, Global Hlth, Brentford, England

[2] Merck & Co Inc, Corp Responsibil, Kenilworth, NJ USA

[3] Bridges Dev, Washington, DC USA

[4] Int Federat Pharmaceut Manufacturers & Assoc, Geneva, Switzerland

[5] Adrian Hopkins Consulting, Gravesend, Kent, England

[6] Pfizer Inc, Global Hlth & Patient Access, New York, NY USA

[7] Johnson & Johnson Global Publ Hlth, New Brunswick, NJ USA

[8] Grp Corp Affairs Merck KGaA, Global Hlth, Darmstadt, Germany

[9] Sanofi, Global Hlth Programs, Paris, France

[10] Gilead Sci, Global Patient Solut Africa, Foster City, CA USA

[11] Bayer AG Pharmaceut, Neglected Trop Dis Programs, Berlin, Germany

[12] Eisai & Co Ltd, Sustainabil, Tokyo, Japan

[13] Novartis Global Hlth & Corp Responsibil, Basel, Switzerland

[14] WHO Geneva, Dept Control Neglected Trop Dis, Geneva, Switzerland

[15] WHO Reg Off South East Asia, Dept Communicable Dis, Delhi, India

[16] WHO Reg Off Africa, Expanded Special Project Eliminat NTDs ESPEN, Brazzaville, Rep Congo

[17] WHO Reg Off Western Pacific, Div Programs Dis Control, Manila, Philippines

[18] Task Force Global Hlth Atlanta, NTD Support Ctr, Atlanta, GA USA

来源：

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2021年 / 115卷 / 02期

关键词：

endemic countries; medicine donations; neglected tropical diseases; partnerships; pharmaceutical companies; 2030 NTD roadmap; PROGRESS;

D O I：

10.1093/trstmh/traa167

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Neglected tropical diseases (NTDs) are targeted for global control or elimination. Recognising that the populations most in need of medicines to target NTDs are those least able to support and sustain them financially, the pharmaceutical industry created mechanisms for donating medicines and expertise to affected countries through partnerships with the WHO, development agencies, non-governmental organisations and philanthropic donors. In the last 30 y, companies have established programmes to donate 17 different medicines to overcome the burden of NTDs. Billions of tablets, capsules, intravenous and oral solutions have been donated, along with the manufacturing, supply chains and research necessary to support these efforts. Industry engagement has stimulated other donors to support NTDs with funds and oversight so that the 'heath benefit' return on investment in these programmes is truly a 'best value in public health'. Many current donations are 'open-ended', promising support as long as necessary to achieve defined health targets. Extraordinary global health advances have been made in filariasis, onchocerciasis, trachoma, trypanosomiasis, leishmaniasis, schistosomiasis, intestinal parasites and others; and these advances are taking place in the context of strengthening health systems and meeting the global development goals espoused by the WHO. The pharmaceutical manufacturers, already strong collaborators in initiating or supporting these disease-targeted programmes, have committed to continuing their partnership roles in striving to meet the targets of the WHO's new NTD roadmap to 2030.

引用

页码：136 / 144

页数：9

共 32 条

[21] The NTD Supply Chain Forum-Strengthening the backbone of NTD programs [J].